Translating evidence into market access across Southeast Asia & APAC

Your strategic partner in evidence & access

SP Health Analytics is a specialist health economics and outcomes research (HEOR), real-world evidence (RWE) and health technology assessment (HTA) / market access consultancy. We help pharmaceutical, biotech and life-science organizations — and their delivery partners — build and defend the value of their products in markets where local payer context decides the outcome.

Start a conversation
About the founder

Sirinthip Petcharapiruch, BSc Pharm, MSc

Founder & Principal Consultant

Sirinthip Petcharapiruch, Founder & Principal Consultant

For 18+ years I have worked at the intersection of evidence and access — generating HEOR and RWE inside leading global pharmaceutical companies, and leading its delivery as a Managing Principal at a global contract research organization (CRO) and specialized consultancy, where I built and scaled an RWE and HEOR practice across Asia-Pacific (APAC) and Southeast Asia (SEA) — growing it to a 25+ consultant team across 500+ projects.


I founded SP Health Analytics to bring that senior, independent perspective directly to the organizations that need it. I sit at the intersection of the sponsors who need evidence, the CROs and consultancies who generate it, and the payers and HTA bodies who judge it — making sure the right evidence is built, by the right partner, with the right solution, to answer the right question. What I bring is “both sides of the table” experience, regional SEA / APAC fluency in HTA, pricing and reimbursement, policy-level reach, and a single senior expert who is accountable — not a layered team.

What we do

Four service pillars

Engagements scale to the need — from a focused advisory input or expert review, to leading the evidence strategy for a launch, to setting up a partner’s capability, to ongoing oversight of a multi-country evidence program. Pillars can be combined.

1 · Evidence strategy & strategic partnering

Identifying and designing the RWE, HEOR and HTA evidence that strengthens the product value proposition and meets payer and market needs across the lifecycle — and connecting sponsors with the right, fit-for-purpose delivery partners.

2 · Building & scaling RWE / HEOR capability

Helping CROs and consultancies set up, scale and extend an RWE and HEOR function across APAC and SEA — from operating model to senior talent and method.

3 · Evidence generation delivery support & oversight

Senior oversight, risk mitigation and quality assurance that de-risk evidence projects — catching issues early and assuring quality and timelines.

4 · Training & expert input

Capability building, advisory boards and senior expert guidance for client teams navigating market access, evidence generation and HTA in the region.

Track record & credentials

Senior experience, regional depth

18+
years across pharma & HEOR / RWE consulting
500+
projects under accountability
~28%
CAGR in practice revenue, APAC & SEA (2022–25)
SEA / APAC
market & payer fluency
Contact

Let’s talk evidence & access

If you are navigating market access, evidence generation or HTA in APAC, or building an RWE / HEOR capability, I would be glad to connect.



Email
s.petcharapiruch@gmail.com

Phone
+66 (0)64 156 1528

LinkedIn
linkedin.com/in/sirin-petcharapiruch-67799060